PCM
Penserra Capital Management Portfolio holdings
AUM
$7.17B
1-Year Return
49.58%
This Quarter Return
+33.7%
1 Year Return
+49.58%
3 Year Return
+118.16%
5 Year Return
+229.83%
10 Year Return
–
AUM
$4.23B
AUM Growth
+$1.6B
(+61%)
Cap. Flow
+$935M
Cap. Flow
% of AUM
22.08%
Top 10 Holdings %
Top 10 Hldgs %
21.32%
Holding
1,174
New
230
Increased
606
Reduced
167
Closed
168
Top Buys
| 1 |
KE Holdings
BEKE
|
+$78.6M |
| 2 |
Lufax Holding
LU
|
+$56.6M |
| 3 |
Groupon
GRPN
|
+$50.3M |
| 4 |
JD.com
JD
|
+$43.7M |
| 5 |
Lands' End
LE
|
+$36.7M |
Top Sells
| 1 |
JMIA
Jumia Technologies
JMIA
|
+$35.9M |
| 2 |
Peloton Interactive
PTON
|
+$31.3M |
| 3 |
Match Group
MTCH
|
+$23.5M |
| 4 |
Fiverr
FVRR
|
+$16.6M |
| 5 |
Stitch Fix
SFIX
|
+$14.7M |
Sector Composition
| 1 | Consumer Discretionary | 35.59% |
| 2 | Technology | 23.48% |
| 3 | Communication Services | 13.86% |
| 4 | Real Estate | 4.37% |
| 5 | Industrials | 4.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Medical Properties Trust
MPW
$2.77B
| $24K | ﹤0.01% |
1,112
+262
| +31% | +$5.66K |
|
827
Raymond James Financial
RJF
$33.2B
| $24K | ﹤0.01% |
389
+83
| +27% | +$5.12K |
|
|
LMNX
828
DELISTED
Luminex Corp
LMNX
| $24K | ﹤0.01% |
1,065
+667
| +168% | +$15K |
|
|
AMTI
829
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $24K | ﹤0.01% |
+810
| New | +$24K |
|
830
Brown & Brown
BRO
$30.5B
| $23K | ﹤0.01% |
497
-1,677
| -77% | -$77.6K |
|
831
Compugen
CGEN
$131M
| $23K | ﹤0.01% |
1,940
+1,234
| +175% | +$14.6K |
|
|
TCRR
832
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $23K | ﹤0.01% |
+765
| New | +$23K |
|
|
ATNX
833
DELISTED
Athenex, Inc. Common Stock
ATNX
| $23K | ﹤0.01% |
107
+72
| +206% | +$15.5K |
|
834
Advance Auto Parts
AAP
$3.55B
| $22K | ﹤0.01% |
145
+9
| +7% | +$1.37K |
|
835
Allegion
ALLE
$14.6B
| $22K | ﹤0.01% |
193
+57
| +42% | +$6.5K |
|
836
Annexon
ANNX
$252M
| $22K | ﹤0.01% |
+885
| New | +$22K |
|
837
Avidity Biosciences
RNA
$5.97B
| $22K | ﹤0.01% |
+870
| New | +$22K |
|
838
Sunrun
RUN
$3.74B
| $22K | ﹤0.01% |
+321
| New | +$22K |
|
|
PETQ
839
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $22K | ﹤0.01% |
580
+366
| +171% | +$13.9K |
|
|
PRVB
840
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $22K | ﹤0.01% |
+1,320
| New | +$22K |
|
841
Amphastar Pharmaceuticals
AMPH
$1.32B
| $21K | ﹤0.01% |
1,090
+686
| +170% | +$13.2K |
|
842
Cboe Global Markets
CBOE
$24.5B
| $21K | ﹤0.01% |
229
+25
| +12% | +$2.29K |
|
843
Nordson
NDSN
$12.6B
| $21K | ﹤0.01% |
+109
| New | +$21K |
|
844
Universal Health Services
UHS
$11.8B
| $21K | ﹤0.01% |
158
+56
| +55% | +$7.44K |
|
845
Akero Therapeutics
AKRO
$3.46B
| $20K | ﹤0.01% |
795
+497
| +167% | +$12.5K |
|
846
Omeros
OMER
$291M
| $20K | ﹤0.01% |
1,415
+883
| +166% | +$12.5K |
|
847
Syndax Pharmaceuticals
SNDX
$1.36B
| $20K | ﹤0.01% |
+940
| New | +$20K |
|
848
Everest Group
EG
$14.3B
| $19K | ﹤0.01% |
84
+16
| +24% | +$3.62K |
|
849
Enanta Pharmaceuticals
ENTA
$178M
| $19K | ﹤0.01% |
465
+295
| +174% | +$12.1K |
|
850
Enova International
ENVA
$2.88B
| $19K | ﹤0.01% |
778
+774
| +19,350% | +$18.9K |
|